Geneos Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $26.9K | Hold |
|
|||||
|
2025
Q2 | $20.2K | Sell |
|
|||||
|
2025
Q1 | $27.9K | Buy |
|
|||||
|
2024
Q4 | $15.9K | Sell |
|
|||||
|
2024
Q3 | $23.7K | Sell |
|
|||||
|
2024
Q2 | $47.5K | Buy |
|
|||||
|
2024
Q1 | $59.4K | Buy |
|
|||||
|
2023
Q4 | $35.1K | Hold |
|
|||||
|
2023
Q3 | $25.4K | Sell |
|
|||||
|
2023
Q2 | $31.5K | Buy |
|
|||||
|
2023
Q1 | $9.32K | Hold |
|
|||||
|
2022
Q4 | $8.37K | Sell |
|
|||||
|
2022
Q3 | $35K | Sell |
|
|||||
|
2022
Q2 | $72K | Sell |
|
|||||
|
2022
Q1 | $71K | Sell |
|
|||||
|
2021
Q4 | $135K | Buy |
|
|||||
|
2021
Q3 | $196K | Buy |
|
|||||
|
2021
Q2 | $275K | Buy |
|
|||||
|
2021
Q1 | $223K | Hold |
|
|||||
|
2020
Q4 | $194K | Buy |
|
|||||
|
2020
Q3 | $94K | Hold |
|
|||||
|
2020
Q2 | $82K | Buy |
|
|||||
|
2020
Q1 | $30K | Sell |
|
|||||
|
2019
Q4 | $73K | Buy |
|
|||||
|
2019
Q3 | $43K | Hold |
|
|||||
|
2019
Q2 | $48K | Hold |
|
|||||
|
2019
Q1 | $36K | Hold |
|
|||||
|
2018
Q4 | $27K | Buy |
|
|||||
|
2018
Q3 | $8K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $25K | Buy |
|